Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France
- Conditions
- Renal Insufficiency, Chronic
- Registration Number
- NCT02938611
- Lead Sponsor
- Centre Hospitalier Universitaire de Nīmes
- Brief Summary
The main objective of this study is to evaluate the feasibility of estimating the prevalence of stage 4 and 5 chronic kidney disease in the Gard department of France from data obtained via laboratory databases. To verifiy if the demand for care thus authenticated by laboratory tests is adapted to nephrology care delivery, as recommended by the French High Authority of Health (HAS), laboratory data will be compared with those of patients seen by nephrologists in the department.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 3375
- chronic kidney disease (stage >= 4)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The prevalence of chronic kidney disease stage > = 4 in the Gard according to laboratory data (%) from baseline (day 0) to 12 months The prevalence of chronic kidney disease stage > = 4 in the Gard according to laboratory data (raw number) from baseline (day 0) to 12 months
- Secondary Outcome Measures
Name Time Method For each nephrologist participating in the study, the % of patients with stage >=4 chronic kidney disease who are correctly declared from baseline (day 0) to 12 months The percentage of patients with CKD stage >= 4 correctly reported by participating nephrologists from baseline (day 0) to 12 months The % of patients with chronic kidney disease stage > = 4 in the Gard according to laboratory data and who are not seen by a nephrologist from baseline (day 0) to 12 months
Trial Locations
- Locations (4)
CHU de Nîmes - Hôpital Universitaire Carémeau
🇫🇷Nîmes Cedex 09, France
AIDER - Unité de Dialyse d'Alès
🇫🇷Alès, France
AIDER - Unité de Dialyse de Nîmes, CHU Carémeau
🇫🇷Nîmes Cedex 09, France
Gardialyse
🇫🇷Nîmes, France